SEC Form 4 · accession 0001437749-26-029220
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Skinner
Officer — Chief Financial Officer
Period of report
Feb 3, 2025
Accepted (ET)
Aug 28, 2026 · 7:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001625101
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $20.93 | Feb 3, 2025 | A | 300,000 | A | — | Feb 3, 2035 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1Half of the shares subject to the option will vest in equal installments on the first, second, third, and fourth anniversaries of the grant date and the remaining shares subject to the option will vest in equal tranches upon the achievement of four performance-based vesting criteria tied to both the Issuer's market capitalization ranging from $2 billion to $5 billion and GAAP revenue targets ranging from $48 million to $175 million, in all cases, subject to the Reporting Person's continued service through each vesting milestone.